Börskollen
Pressmeddelanden från SyntheticMR
11 feb 16:51
SyntheticMRSyntheticMR’s rights issue has been registered – conversion of BTA into shares11 feb 16:50SyntheticMRSyntheticMR:s företrädesemission är registrerad – omvandling av BTA till aktier06 feb 08:30SyntheticMRYear-End report January – December 202506 feb 08:29SyntheticMRBokslutskommuniké januari - december 202504 feb 15:16SyntheticMRSyntheticMR publishes the outcome of the rights issue04 feb 15:14SyntheticMRSyntheticMR offentliggör utfall i företrädesemissionen20 jan 07:19SyntheticMRToday the subscription period commences in SyntheticMR AB’s rights issue20 jan 07:17SyntheticMRIdag inleds teckningsperioden i SyntheticMR AB:s företrädesemission19 jan 13:51SyntheticMRSyntheticMR AB publishes information document regarding the rights issue19 jan 13:50SyntheticMRSyntheticMR AB offentliggör informationsdokument avseende företrädesemission19 jan 08:48SyntheticMRSyntheticMR AB publishes financial guidance ahead of the forthcoming rights issue19 jan 08:47SyntheticMRSyntheticMR AB offentliggör finansiell guidning inför förestående företrädesemission16 jan 09:15SyntheticMRRegulatory Approval for ARIA Monitoring Strengthens SyntheticMR’s Position with a Broader Neuroimaging Offering16 jan 09:15SyntheticMRRegulatoriskt godkännande för ARIA-monitorering stärker SyntheticMRs position som en ledande aktör inom neurodiagnostik med ett bredare erbjudande15 jan 08:46SyntheticMRSyntheticMR AB announces intention to publish financial guidance ahead of upcoming rights issue15 jan 08:44SyntheticMRSyntheticMR AB meddelar avsikt att publicera finansiell guidning inför förestående företrädesemission09 jan 12:08SyntheticMRReport from the extraordinary general meeting in SyntheticMR AB (publ)09 jan 12:06SyntheticMRKommuniké från extra bolagsstämma i SyntheticMR AB (publ)18 dec 2025 09:01SyntheticMRNotice of extra general meeting in SyntheticMR AB (publ)18 dec 2025 09:00SyntheticMRKallelse till extra bolagsstämma i SyntheticMR AB (publ)17 dec 2025 23:03SyntheticMRSyntheticMR AB resolves on a fully secured rights issue of approximately SEK 32.8 million17 dec 2025 23:00SyntheticMRSyntheticMR AB beslutar om fullt säkerställd företrädesemission om cirka 32,8 miljoner kronor28 nov 2025 08:00SyntheticMRInterim report July – September 202528 nov 2025 08:00SyntheticMRDelårsrapport juli – september 202525 nov 2025 19:07SyntheticMRSyntheticMR AB (publ) postpones the interim report for the third quarter of 202525 nov 2025 19:04SyntheticMRSyntheticMR AB (publ) senarelägger delårsrapport för tredje kvartalet 202522 nov 2025 15:53SyntheticMRMarcel Warntjes resigns from the Board of Directors of SyntheticMR AB (publ)22 nov 2025 15:52SyntheticMRMarcel Warntjes avgår ur styrelsen för SyntheticMR AB (publ)29 okt 2025 08:50SyntheticMRNomination Committee appointed for the 2026 Annual General Meeting in SyntheticMR29 okt 2025 08:49SyntheticMRValberedning utsedd inför årsstämman 2026 i SyntheticMR01 sep 2025 08:18SyntheticMRLena Åredal Assumes Role as CEO of SyntheticMR AB (publ)01 sep 2025 08:17SyntheticMRLena Åredal tillträder som ny VD för SyntheticMR AB (publ)26 aug 2025 08:07SyntheticMRInterim report April– June 202526 aug 2025 08:05SyntheticMRDelårsrapport april – juni 202513 jun 2025 08:56SyntheticMRLena Åredal Appointed New CEO of SyntheticMR AB (publ)13 jun 2025 08:55SyntheticMRLena Åredal utsedd till ny VD för SyntheticMR AB (publ)03 jun 2025 10:30SyntheticMRNew Multicenter Study Demonstrates SyMRI’s Potential to Transform Clinical Neuroimaging Workflows20 maj 2025 18:59SyntheticMRReport from Annual General Meeting in SyntheticMR AB (publ)20 maj 2025 18:59SyntheticMRKommuniké från årsstämman i SyntheticMR AB (publ)20 maj 2025 08:18SyntheticMRInterim report January – March 202520 maj 2025 08:17SyntheticMRDelårsrapport januari – mars 202522 apr 2025 08:48SyntheticMRNotice to attend the annual general meeting of SyntheticMR AB (publ)22 apr 2025 08:47SyntheticMRKallelse till årsstämma i SyntheticMR AB (publ)16 apr 2025 08:42SyntheticMRSyntheticMR publishes annual report for 202416 apr 2025 08:40SyntheticMRSyntheticMR publicerar årsredovisningen för 202425 feb 2025 08:43SyntheticMRYear-End report January – December 202425 feb 2025 08:40SyntheticMRBokslutskommuniké januari – december 202417 feb 2025 18:12SyntheticMRValberedningen föreslår Gisli Hennermark som ny styrelseordförande för SyntheticMR AB (publ)30 jan 2025 13:05SyntheticMRSyntheticMR Receives Regulatory Clearance of SyMRI 3D in Japan21 jan 2025 20:28SyntheticMRSyntheticMR AB (publ) appoints CFO Johanna Norén as Acting CEO21 jan 2025 20:27SyntheticMRSyntheticMR AB (publ) utser CFO Johanna Norén till tillförordnad VD17 jan 2025 18:30SyntheticMRVedran Beglerbegovic appointed as new CEO of SyntheticMR AB (publ)17 jan 2025 18:28SyntheticMRVedran Beglerbegovic utses till ny VD för SyntheticMR AB (publ)16 jan 2025 08:14SyntheticMRSyntheticMR announces final outcome in the oversubscribed rights issue16 jan 2025 08:11SyntheticMRSyntheticMR offentliggör slutligt utfall i den övertecknade företrädesemissionen14 jan 2025 13:58SyntheticMRSyntheticMR’s rights issue oversubscribed – preliminary outcome is announced14 jan 2025 13:54SyntheticMRSyntheticMRs företrädesemission övertecknad – preliminärt utfall offentliggörs02 jan 2025 18:57SyntheticMRSyntheticMR completes the acquisition of Combinostics Oy02 jan 2025 18:55SyntheticMRSyntheticMR fullbordar förvärvet av Combinostis Oy20 dec 2024 08:33SyntheticMRSyntheticMR publishes disclosure document regarding rights issue20 dec 2024 08:31SyntheticMRSyntheticMR offentliggör informationsdokument avseende företrädesemission17 dec 2024 14:51SyntheticMRAnnouncement from extra general meeting in SyntheticMR AB (publ)17 dec 2024 14:49SyntheticMRKommuniké från extra bolagsstämma i SyntheticMR AB (publ)06 dec 2024 20:44SyntheticMRSyntheticMR receives FDA 510(k) clearance for SyMRI 1504 dec 2024 16:23SyntheticMRSyntheticMR AB (publ) appoints Vedran Beglerbegovic as Acting CEO for SyntheticMR04 dec 2024 16:19SyntheticMRSyntheticMR AB (publ) utser Vedran Beglerbegovic till tillförordnad VD för SyntheticMR28 nov 2024 23:10SyntheticMRKallelse till extra bolagsstämma i SyntheticMR AB (publ)28 nov 2024 23:10SyntheticMRNotice of extra general meeting in SyntheticMR AB (publ)28 nov 2024 23:05SyntheticMRSyntheticMR resolves on a rights issue of approximately SEK 65 million28 nov 2024 23:05SyntheticMRSyntheticMR beslutar om en företrädesemission om cirka 65 miljoner kronor28 nov 2024 22:55SyntheticMRSyntheticMR signs agreement to acquire Finnish Combinostics Oy28 nov 2024 22:55SyntheticMRSyntheticMR ingår avtal om att förvärva finska Combinostics Oy22 nov 2024 15:00SyntheticMRNomination Committee appointed for the 2025 Annual General Meeting in SyntheticMR22 nov 2024 14:57SyntheticMRValberedning utsedd inför årsstämman 2025 i SyntheticMR18 nov 2024 08:14SyntheticMRInterim report July – September 202418 nov 2024 08:11SyntheticMRDelårsrapport juli - september 202406 nov 2024 18:52SyntheticMRSyntheticMR AB (publ) brings forward the publication date of the interim report for the period 1 January – 30 September 2024 to Monday, 18 November 2024.06 nov 2024 18:49SyntheticMRSyntheticMR AB (publ) tidigarelägger offentliggörandet av delårsrapport för perioden 1 januari – 30 september 2024 till måndagen den 18 november 2024.29 okt 2024 11:27SyntheticMRSyntheticMR Receives Regulatory Approval for SyMRI 15 in Australia02 okt 2024 10:15SyntheticMRSyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland25 sep 2024 10:00SyntheticMRSyntheticMR Announces Regulatory Clearance for SyMRI 15 in the UK04 sep 2024 10:00SyntheticMRSyntheticMR Announces the Appointment of Francois Hebert as New President, North America27 aug 2024 08:49SyntheticMRInterim report April – June 202427 aug 2024 08:46SyntheticMRDelårsrapport april – juni 202419 aug 2024 10:48SyntheticMRSyntheticMR Receives Regulatory Approval for SyMRI in Taiwan09 jul 2024 21:34SyntheticMRSyntheticMR announces estimated net sales of SEK 12m. (21.2) for quarter 2 of 2024 depending on organizational changes in USA. The net sales target for 2024 is therefore not expected to be achieved09 jul 2024 21:31SyntheticMRSyntheticMR meddelar uppskattad nettoomsättning 12 miljoner kronor (21,2) för andra kvartalet 2024 beroende på organisationsförändringar i USA. Omsättningsmålet för 2024 förväntas därmed inte uppnås26 jun 2024 13:30SyntheticMRSyMRI 15 by SyntheticMR obtains CE-Marking22 maj 2024 08:22SyntheticMRReport from Annual General Meeting in SyntheticMR AB (publ)22 maj 2024 08:21SyntheticMRKommuniké från årsstämman i SyntheticMR AB (publ)21 maj 2024 08:08SyntheticMRInterim report January – March 202421 maj 2024 08:05SyntheticMRDelårsrapport januari – mars 202419 apr 2024 08:01SyntheticMRNotice to attend the annual general meeting of SyntheticMR AB (publ)19 apr 2024 08:00SyntheticMRKallelse till årsstämma i SyntheticMR AB (publ)19 apr 2024 07:31SyntheticMRSyntheticMR publishes annual report for 202319 apr 2024 07:30SyntheticMRSyntheticMR publicerar årsredovisningen för 202317 apr 2024 10:15SyntheticMRSyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR’s SyMRI NEURO Software at SimonMed Facilities.16 apr 2024 09:58SyntheticMRValberedningen föreslår Johanna Fälting och Gisli Hennermark som nya styrelseledamöter i SyntheticMR AB (publ)27 mar 2024 11:01SyntheticMRSyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D12 mar 2024 18:12SyntheticMRDecided allocation regarding incentive program LTIP 2024 and TO 2
SyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMRSyntheticMR